Trials / Conditions / Fecal Incontinence

Fecal Incontinence

215 registered clinical trials studyying Fecal Incontinence — 28 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Axonics R20 Post-Market Clinical Follow-up (PMCF) Study for the Indication of Fecal Incontinence NCT07499258	Axonics, Inc.	—
Not Yet Recruiting	Use of a β-Glucan Cream in Incontinence-Associated Dermatitis NCT07524439	University of Alberta	Phase 1 / Phase 2
Not Yet Recruiting	Testing a Novel Barrier Cream for Fecal Incontinence in an Ambulatory Population NCT06370637	Scotiaderm	N/A
Not Yet Recruiting	Mechanisms of Fecal Incontinence in Wolfram Syndrome NCT07313085	Hôpital Necker-Enfants Malades	—
Not Yet Recruiting	Pelvic Floor Disorder Symptoms in Women Seeking Weight Loss Therapy NCT07175805	Hartford HealthCare	—
Not Yet Recruiting	Testing the Safety and Efficacy of a Novel Barrier Cream for the Treatment of Moisture Associated Skin Damage NCT06221046	Scotiaderm	N/A
Recruiting	Mechanisms of Improving Fecal Continence Muscles Motor Function NCT06532123	Medical College of Wisconsin	N/A
Not Yet Recruiting	Functional Outcomes in Ulcerative Colitis Patients With Ileal Pouch Anal Anastomosis Treated With High Intensi NCT07034443	Cedars-Sinai Medical Center	N/A
Not Yet Recruiting	Enema Device for Children With Spina Bifida NCT05253196	University of Colorado, Denver	N/A
Recruiting	Mechanisms of Action on Rectal Motricity of Intrarectal Botulinum Toxin Injections NCT05998187	University Hospital, Rouen	Phase 3
Recruiting	Safety and Performance of UCon Patch Electrode NCT06754189	InnoCon Medical	N/A
Enrolling By Invitation	Late Side-effects After Cervical Cancer Treatment - Prevention and Treatment NCT06786091	St. Olavs Hospital	N/A
Not Yet Recruiting	Intra-rectal Botulinum Toxin Injection for Intractable Non-retentive Fecal Incontinence in Children - an Open NCT06785844	Shaare Zedek Medical Center	EARLY_Phase 1
Recruiting	Sacral Neuromodulation and Faecal Incontinence and Its Unknown Effect on the External Anal Sphincter NCT06763861	Umeå University	—
Recruiting	Multidimensional Examination of Patients with Colorectal and Anal Cancer NCT06562140	University of Pecs	—
Not Yet Recruiting	Effect of Pelvic Rehabilitation After Low Anterior Resection for Cancer Rectum. - A Randomised Controlled Tria NCT06524362	GEM Hospital & Research Center	N/A
Unknown	Prevalence of Anal Sphincter Defects After Childbirth NCT05196620	Universidad de Zaragoza	—
Recruiting	Treatment of Fecal Incontinence and Functional Evacuation Disorders Using Non-instrumental Biofeedback NCT06273046	Hospital Universitari Vall d'Hebron Research Institute	N/A
Active Not Recruiting	Iltamiocel Compared to Placebo for Chronic Fecal Incontinence in Females With Obstetric Injury NCT05776277	Cook MyoSite	Phase 3
Active Not Recruiting	Use of the LEVA® Pelvic Health System for Fecal Incontinence NCT06152224	University of Wisconsin, Madison	Phase 4
Recruiting	Safety and Performance of UCon Bar Electrode for the Treatment of Overactive Bladder (OAB) and Bowel Dysfuncti NCT06091566	InnoCon Medical	N/A
Unknown	The Safety and Efficacy of 5-HT3 Receptor Antagonist (Ramosetron) for the Treatment of Fecal Incontinence NCT06166615	Seoul National University Hospital	Phase 2 / Phase 3
Completed	Lidocaine Patches Prior to Percutaneous Nerve Evaluation NCT05783219	University of Louisville	Phase 2
Unknown	The Use of Electrical Stimulation to Increase Anal Pressures NCT05841953	Shaare Zedek Medical Center	N/A
Active Not Recruiting	Treatment of Fecal Incontinence and Chronic Constipation With Low-volume Irrigation NCT05773742	Aarhus University Hospital	N/A
Active Not Recruiting	Safety and Performance of a Silicone Implant for Fecal Incontinence Treatment (SimplyFI) NCT05708612	A.M.I. Agency for Medical Innovations GmbH	N/A
Recruiting	Home Biofeedback Therapy for Dyssynergic Defecation, Fecal Incontinence and Urinary Incontinence NCT05771597	Augusta University	N/A
Recruiting	Acute Genital Nerve Stimulation for Neurogenic Bowel Dysfunction in Individuals Living With Spinal Cord Injury NCT05626816	MetroHealth Medical Center	N/A
Recruiting	Trial to Evaluate Fecobionics in Fecal Incontinence (FI) (NORMAL and ABNORMAL-FI) NCT05412069	The California Medical Innovations Institute, Inc.	N/A
Completed	Validity and Reliability of the Turkish St. Marks Incontinence Score NCT05755763	Atlas University	—
Completed	Perineal Massage and Pelvic Floor Exercise in the Antenatal Period NCT05624060	Bitlis Eren University	N/A
Recruiting	Autologous Muscle Fiber Fragment Injections NCT05396456	Wake Forest University Health Sciences	N/A
Active Not Recruiting	Implantation of BioSphincter TM for Treatment of Severe Passive Fecal Incontinence NCT05616208	Cellf Bio LLC	Phase 1
Recruiting	Evaluation of the Efficacy and Safety of Autologous Fat Injection Into the Intersphincter Space in Fecal Incon NCT04972799	Rennes University Hospital	N/A
Completed	Management of FI After Surgery of ARM NCT05621629	Shengjing Hospital	—
Recruiting	Skeletal Muscle-derived Cell Implantation for Treatment of Fecal Incontinence NCT04976153	Innovacell GmbH	Phase 3
Completed	Transdermal Administration by a Novel Wireless Iontophoresis Device NCT06351852	James J. Peters Veterans Affairs Medical Center	EARLY_Phase 1
Completed	Safety and Performance of UCon for the Treatment of the Symptoms of Overactive Bladder (OAB) / Bowel Dysfuncti NCT05368246	InnoCon Medical	N/A
Recruiting	Pelvic Health Electrically Evoked Recording (PEER) 2 Study NCT05200923	MedtronicNeuro	N/A
Completed	Safety and Efficacy of Concurrent MACE and Mitrofanoff Procedures NCT07206719	Mohammad Daboos	N/A
Unknown	Sacral Neuromodulation in Neurogenic Patients NCT05688644	Omri Schwarztuch Gildor	—
Terminated	Pelvic Floor Disorders Among Sexual Minoritized Women NCT05072158	University of New Mexico	—
Completed	Examination of a New Irrigation System for Transanal Irrigation in Children With Fecal Incontinence NCT05032534	University of Aarhus	N/A
Completed	Effects of Single Dose Tadalafil on Urethral and Anal Closure Function NCT05095077	University Hospital Bispebjerg and Frederiksberg	Phase 1
Completed	The Role of Fiber in the Prevention and Treatment of Fecal Incontinence NCT04806386	Massachusetts General Hospital	N/A
Unknown	The Role of Active Administration of Peristeen Bowel Evacuation for the Management of Urinary Tract Infection NCT04815226	Seoul National University Hospital	N/A
Terminated	Fecal Microbial Transplantation for the Treatment of Fecal Incontinence in Women NCT04201821	University of Pennsylvania	Phase 1 / Phase 2
Completed	Trial to Evaluate Fecobionics in Healthy Subjects and Patients NCT04766138	The California Medical Innovations Institute, Inc.	N/A
Completed	Obstetric Fecal Incontinence Treatment Registry NCT04727463	Hospital San Carlos, Madrid	—
Recruiting	Comparing Transanal Irrigation With Navina Smart vs. Standard Bowel Care in Patients With Multiple Sclerosis NCT04707976	Wellspect HealthCare	N/A
Completed	Axonics SacRal NeuromodulaTIon System RegisTRY Study NCT05064384	Axonics, Inc.	—
Active Not Recruiting	Neostigmine and Glycopyrrolate by Iontophoresis NCT06351995	James J. Peters Veterans Affairs Medical Center	Phase 3
Completed	Effect of Anorectal Biofeedback on Encopresis in School Aged Girls After Sexual Assault NCT04652024	Badr University	N/A
Completed	Severity of Fecal Incontinence and Manometric Values Using the Anopress® Device in Women NCT05058326	Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta	—
Withdrawn	BTL Emsella Chair Versus Sham for the Treatment of Fecal Incontinence NCT04138602	Corewell Health East	N/A
Terminated	InterStim Micro Post Market Clinical Follow-up Study (ELITE) NCT04506866	MedtronicNeuro	N/A
Completed	Do Prostheses of SphinkeeperTM Migrate After Operation? NCT04992429	Medical University of Vienna	—
Completed	Pharmacokinetics of Neostigmine and Glycopyrrolate NCT04027972	James J. Peters Veterans Affairs Medical Center	EARLY_Phase 1
Completed	Effects of Single Dose Citalopram and Reboxetine on Urethral and Anal Closure Function on Healthy Female Subje NCT04097288	University Hospital Bispebjerg and Frederiksberg	Phase 1
Recruiting	Sacral Neuromodulation as Treatment for Fecal Incontinence NCT03825575	McMaster University	N/A
Unknown	Use of the Leva Pelvic Digital Health System in Women With Fecal Incontinence NCT04027335	Renovia, Inc.	N/A
Suspended	BAFIARS - Biomedical Assessment of Function and Imaging of the Ano-rectal Sphincter NCT02778048	Insel Gruppe AG, University Hospital Bern	—
Unknown	Translumbosacral Neuromodulation for FI NCT03899181	Augusta University	N/A
Completed	Symptoms and Treatment Assessment of Ano-Rectal Disorders in Multiple Sclerosis Patients : STAR-Q NCT04996186	Pierre and Marie Curie University	—
Unknown	Assessment of Faecal Incontinence With MAPLe NCT03969069	University College London Hospitals	—
Completed	Effects of an Anal Insert Device in Fecal Incontinence NCT03898778	Minnesota Medical Technologies	N/A
Unknown	PRP Injection Into Anal Sphincters for Fecal Incontinence NCT04063293	Istanbul Medipol University Hospital	EARLY_Phase 1
Unknown	Pursuit: Real World Use of the Eclipse System NCT03940573	Pelvalon, Inc.	N/A
Unknown	Fat Grafting Technique for Fecal Incontinence NCT03882632	Melanie Salerno, RN	N/A
Withdrawn	Effects of Eluxadoline (Viberzi®) 100 mg Twice Daily on Diarrhea-Associated Fecal Incontinence NCT03489265	University of North Carolina, Chapel Hill	Phase 2
Completed	Fecal Incontinence Treatment (FIT) Study NCT03811821	Mayo Clinic	N/A
Unknown	Validation of a Multimodal Algorithm for the Treatment of Fecal Incontinence NCT05026970	Hospital de Mataró	N/A
Unknown	Safety and Effectiveness Evaluation of the ForConti Contix Fecal Incontinence Management System (FIMS) NCT03813251	ForConti Medical	N/A
Unknown	Indirect Non-invasive Evaluation of Pudendal Neuropathy NCT03933683	University of Campania Luigi Vanvitelli	—
Unknown	Intra-anal Oxymetazoline in Healthy Adult Volunteers NCT03529487	RDD Pharma Ltd	Phase 1
Completed	What is the Prevalence of Female Pelvic Floor Disorders in Minnesota? NCT03536221	University of Minnesota	—
Completed	Incontinence Management System ICU Field Evaluation NCT03628833	Hill-Rom	N/A
Completed	Bladder Antimuscarinic Medication and Accidental Bowel Leakage NCT03543566	University of Alabama at Birmingham	—
Completed	Biofeedback Vs Electrical Stimulation in Treatment of Fecal Incontinence NCT04380571	Cairo University	N/A
Unknown	Function Following Laser for Anal Intraepithelial Neoplasia (FLAN) NCT04109573	Homerton University Hospital NHS Foundation Trust	N/A
Unknown	Comparison of Anorectal Manometry and 3D Manometry in Diagnosis of Functional Disorders in Children NCT02812823	Medical University of Warsaw	N/A
Completed	OptiLUTS Part C: the Development of a Symptom Assessment Tool in Sacral Neuromodulation. NCT05313984	University Hospital, Ghent	—
Unknown	Bulking Agent Versus Electrostimulation Therapy in Anal Incontinence NCT03052946	University of Sao Paulo	Phase 2 / Phase 3
Completed	Neuromodulation for Accidental Bowel Leakage NCT03278613	NICHD Pelvic Floor Disorders Network	N/A
Completed	Diet and Fecal Incontinence in Senior Women NCT03510052	University of Pennsylvania	N/A
Terminated	Treatment of Anal Incontinence With Intersphincteric Implants NCT03080753	Region Skane	N/A
Completed	Transcutaneous Posterior Nerve Stimulation inTreatment of Fecal Incontience NCT04478799	Batterjee Medical College	N/A
Completed	Physical Therapy for Anal Incontinence NCT03252951	San Diego State University	N/A
Completed	Studies in Patients With Defecatory Disorders NCT03317938	Giome	N/A
Active Not Recruiting	Lateral Episiotomy or Not in Vacuum Assisted Delivery in Non-parous Women NCT02643108	Karolinska Institutet	N/A
Completed	Does Single Dose Imipramine Affect the Opening Pressure of the Urethral and Anal Sphincter? NCT03102645	Jonatan Kornholt	Phase 1
Completed	Evaluating the Impact of Automated Evaluation of Gastrointestinal Symptoms (AEGIS) on Clinical Outcomes NCT02530216	Cedars-Sinai Medical Center	N/A
Unknown	Transverse Coloplasty vs. Side-to-end Anastomosis Following Low Anterior Resection (LAR): CSAR Trial NCT03074461	Ludwig-Maximilians - University of Munich	N/A
Completed	Safety, Efficacy and Quality of Life of Sphinkeeper Implantation for Fecal Incontinence NCT06958497	Academy of Applied Medical and Social Sciences, Poland	—
Completed	The Use of an "Anal-Tape" in Patients With Fecal Incontinence NCT02989545	Shaare Zedek Medical Center	N/A
Completed	Sacral Nerve Stimulation for Faecal Incontinence - Placebo or Clinical Effective NCT03261622	University of Aarhus	N/A
Completed	LIBERATE - PRO: Eclipse™ System Registry NCT03028636	Pelvalon, Inc.	—
Completed	First Time Mothers and Anal Incontinence Six Years Postpartum NCT02792244	Ostfold Hospital Trust	—
Terminated	Treating Anorectal Dysfunction in MS NCT02609607	David Levinthal	Phase 2
Completed	Long Term Efficacy of Sacral Nerve Modulation (SNM) in Patients With Constipation or Stool Incontinence NCT02836717	Cantonal Hospital of St. Gallen	—
Completed	Feasibility Study of the Use of the gekoTM Device for Faecal Incontinence in Older People Living at Home or in NCT02875665	Firstkind Ltd	N/A
Completed	Percutaneous Nerve Evaluation With Fluoroscopy Versus Without NCT02677753	University of Louisville	N/A
Unknown	Tibial Nerve Stimulation in Combination With Biofeedback NCT02888899	University Hospital, Linkoeping	N/A
Completed	A Within Subjects Comparison of Two Antegrade Flushing Regimens in Children NCT02435069	Nemours Children's Clinic	Phase 4
Unknown	Safety and Effectiveness Evaluation of the ForConti Fecal Management System - Pilot Study NCT02865291	ForConti Medical	N/A
Completed	Effect and Tolerance of Botulinum A Toxin Rectal Injections on Fecal Incontinence NCT02414425	University Hospital, Rouen	Phase 3
Completed	A Study of Colesevelam in Fecal Incontinence NCT02628626	Mayo Clinic	Phase 3
Completed	Home Versus Office Biofeedback Therapy for Fecal Incontinence NCT03216291	Augusta University	N/A
Completed	Pilot: Mind Over Matter: Healthy Bowels, Healthy Bladder NCT02671747	University of Wisconsin, Madison	N/A
Completed	Diet and Stool Metabolites in Fecal Incontinence NCT02485522	University of Pennsylvania	—
Completed	A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in NCT02428595	Pelvalon, Inc.	N/A
Completed	Faecal Incontinence iNtervention Study NCT02355834	London North West Healthcare NHS Trust	N/A
Completed	Neuromodulation Therapy for Fecal Incontinence NCT02556151	Augusta University	N/A
Completed	Assessment of Anatomic, Physiologic and Biomechanical Characteristics of the Anal Canal and Pelvic Floor. An O NCT02263170	Insel Gruppe AG, University Hospital Bern	—
Terminated	Sacral Neuromodulation in Dual Incontinence: Ultrasound and Afferent Nerve Sensation Assessment NCT02357784	Northwestern University	N/A
Completed	Treatment of Fecal Incontinence Using Allogenic-Adipose-derived Mesenchymal Stem Cells: A Prospective, Dose Es NCT02384499	Yonsei University	Phase 1
Recruiting	Indiana University Gastrointestinal Motility Diagnosis Registry NCT04506593	Indiana University	—
Completed	The Effect of Oxymetazoline Gel on Anal Pressure and Incontinence in Spinal Cord Injury Patients NCT02299557	RDD Pharma Ltd	Phase 1 / Phase 2
Completed	Comparing the Effectiveness of Two Dietary Interventions for Fecal Incontinence NCT02828384	University of Michigan	Phase 2
Withdrawn	Efficacy, Safety, and Performance Study of a Novel Device Designed to Manage Fecal Incontinence in Hospitalize NCT02208258	Consure Medical Pvt. Ltd.	N/A
Completed	Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform NCT02436057	Cedars-Sinai Medical Center	N/A
Completed	Fecal Incontinence Subtypes in Women With Pelvic Floor Disorders NCT02772874	University of Pennsylvania	—
Completed	Effect of an Educational Program for Staff in Nursing Homes Concerning Patients Fecal Incontinence NCT02183740	Norwegian University of Science and Technology	N/A
Completed	Endoscopically Assisted Colostomy With Colopexy for Critically Ill Patients Without General Anesthesia or Lapa NCT02308631	University of Sao Paulo	Phase 1
Completed	Controlling Anal Incontinence by Performing Anal Exercises With Biofeedback or Loperamide (CAPABLe) NCT02008565	NICHD Pelvic Floor Disorders Network	Phase 3
Withdrawn	Comparison of PTNS and Biofeedback for Fecal Incontinence NCT01882101	Seoul National University Hospital	Phase 3
Suspended	Medical and Economic Evaluation of a Magnetic Anal Sphincter for Patients With Severe Anal Incontinence NCT01920607	Nantes University Hospital	N/A
Unknown	Stem Cells Therapy for Fecal Incontinence in Children After Posterior Sagittal Ano-rectoplasty NCT02161003	Al-Azhar University	Phase 1 / Phase 2
Completed	Effectiveness of Hypopressive Exercises Versus Pelvic-perineal Physiotherapy NCT02259712	University of Alcala	N/A
Completed	NASHA/Dx as a Perianal Implant for the Treatment of Persistent Fecal Incontience After Anorectal Malformation NCT03746834	Uppsala University	Phase 4
Completed	French Post-Inscription Study on Sacral Neuromodulation in the Treatment of Fecal Incontinence NCT01957969	MedtronicNeuro	—
Completed	A Pilot Study to Evaluate Educational Programs to Improve Fecal Incontinence Care in Nursing Homes NCT01939821	Norwegian University of Science and Technology	N/A
Completed	Utility of an Animated Bowel Biofeedback Training Routine to Improve Bowel Function in Individuals With SCI NCT02406859	VA Office of Research and Development	N/A
Unknown	Treatment of Fecal Incontinence by Injection of Autologous Muscle Fibers Into the Anal Sphincter NCT01949922	Herlev Hospital	N/A
Completed	Autologous Cell Therapy for Treatment of Fecal Incontinence NCT01600755	Cook MyoSite	Phase 1 / Phase 2
Completed	Standard Versus Mnemonic Counseling for Fecal Incontinence NCT01778660	University of New Mexico	N/A
Completed	Study of the Efficacy of 4 Treatments for Fecal Incontinence in Community-dwelling Women NCT03394794	Hospital de Mataró	N/A
Completed	Psychometric Validation of a French Version of the PISQ-R and a New Questionnaire About Sexuality NCT01632839	Centre Hospitalier Universitaire de Nīmes	—
Completed	Effect of Sacral Nerve Stimulation on Enteric Nervous System NCT01786304	University Hospital, Rouen	—
Unknown	Value of Anorectal Manometry Before Ileo- or Sigmoidostomy Closure After Rectal Resection NCT02196597	German Society for Neurogastroenterology and Motility	—
Terminated	Educational-Medical-Behavioral Treatment of Fecal Incontinence NCT01717456	University of North Carolina, Chapel Hill	N/A
Completed	Anal Motor Function in Fecal Incontinence NCT01786317	University Hospital, Rouen	N/A
Unknown	The Effect of Physiotherapy for the Treatment of Fecal Incontinence. NCT01705535	Copenhagen University Hospital, Hvidovre	N/A
Completed	Normal Values in Ano-rectal 3D High Resolution Manometry NCT01710579	Hospices Civils de Lyon	N/A
Terminated	Prospective, Multicenter Trial to Investigate the Safety and Efficacy of Percutaneous Tibial Nerve Stimulation NCT01666405	Uroplasty, Inc	Phase 1
Completed	Delivery Method and Risk for Urogenital Prolapse 15-20 Years Later NCT01766193	Norwegian University of Science and Technology	—
Completed	A Clinical Evaluation of a Vaginal Bowel Control System for the Treatment of Fecal Incontinence in Women (LIFE NCT01655498	Pelvalon, Inc.	N/A
Completed	Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (So NCT01647906	Bausch Health Americas, Inc.	—
Completed	Validation of a New Sexuality Questionnaire for Patients With Urinary Incontinence or Pelvic Organ Prolapse NCT01548989	Centre Hospitalier Universitaire de Nīmes	—
Completed	Validation of a French Version of the PISQ-R NCT01548976	Centre Hospitalier Universitaire de Nīmes	—
Completed	Treatment of Fecal Incontinence After Obstetric Anal Sphincter Injuries NCT01528995	University Hospital of North Norway	N/A
Completed	Autologous Myoblast Intrasphincteric Injection for Fecal Incontinence NCT01523522	University Hospital, Rouen	Phase 2 / Phase 3
Completed	FENIX™ Continence Restoration System Registry NCT04007250	Torax Medical Incorporated	—
Completed	Effects of Inferior Mesenteric Artery Preservation in Laparoscopic Colorectal Resection for Diverticular Disea NCT06506552	University of Roma La Sapienza	N/A
Terminated	Gore-BioA Fistula Plug to Treat Transsphincteric Fistulas NCT01584752	Central Finland Hospital District	—
Completed	An Study to Examine the Effect of Coated Suppositories on Anal Pressure in Healthy Subjects NCT01265485	RDD Pharma Ltd	Phase 1 / Phase 2
Completed	Risk Factors for Anal Sphincter Damage During Vaginal Delivery NCT01310426	Hadassah Medical Organization	—
Terminated	Does Percutaneous Tibial Nerve Stimulation (PTNS) Improve Outcomes in Patients Presenting With Fecal Incontine NCT01274585	Massachusetts General Hospital	N/A
Completed	Effect of 7 Days of Dosing With a 10 mg Rectal Suppository of NRL001in Patients With Faecal Incontinence NCT01175941	Norgine	Phase 1
Completed	Behavioral Therapy Of Obstetric Sphincter Tears NCT01166399	NICHD Pelvic Floor Disorders Network	—
Completed	Improving the Efficacy of Sacral Nerve Stimulation for Fecal Incontinence by Alteration of Stimulation Paramet NCT01254695	University of Aarhus	N/A
Terminated	Comparison of the Efficacy of a Biological Implant to Reinforce Overlapping Sphincter Repair Versus Overlappin NCT01044589	Massarat Zutshi	N/A
Completed	Safety, Tolerability, Pharmacodynamic and Pharmacokinetics of a Single Rectal Application of 10 mg NRL001 in E NCT01099683	Norgine	Phase 1
Completed	Clinical Study to Investigate the Effectiveness of the TOPAS System to Treat Fecal Incontinence NCT01090739	ASTORA Women's Health	N/A
Completed	Dose Response Curve - Sacral Nerve Stimulation for Faecal Incontinence NCT01130870	University of Aarhus	N/A
Completed	Safety, Tolerability, Pharmacodynamic and Pharmacokinetics of 7.5, 10, 12.5 or 15 mg NRL001 in a 2 g Supposito NCT01099670	Norgine	Phase 1
Completed	Cerebral Responses During Bilateral/Unilateral Sacral Nerve Stimulation for Idiopathic Faecal Incontinence NCT01095029	University of Aarhus	N/A
Completed	Comparison of Sacral Nerve Modulation and Pudendal Nerve Stimulation in Treatment of Fecal Incontinence NCT01069016	Cantonal Hospital of St. Gallen	N/A
Completed	Percutaneous Tibial Nerve Stimulation for Patients With Fecal Incontinence NCT01162525	Cantonal Hospital of St. Gallen	N/A
Withdrawn	Imodium Syrup Versus Imodium Tablets for Faecal Incontinence NCT00933465	University Hospital Southampton NHS Foundation Trust	Phase 4
Completed	Percutaneous Tibial Nerve Stimulation for the Treatment of Fecal Incontinence NCT00977652	University Hospital, Rouen	Phase 2
Completed	Percutaneous Tibial Nerve Stimulation in the Treatment of Fecal Incontinence NCT00974909	Maastricht University Medical Center	Phase 3
Completed	J-Pouch vs Side-to-End Anastomosis After Hand-Assisted Laparoscopic Low Anterior Resection for Rectal Cancer NCT02627729	Dr. Lutfi Kirdar Kartal Training and Research Hospital	N/A
Completed	Prevalence and Treatment of Anal Incontinence (AI) in Primiparous Women NCT00970320	Ostfold Hospital Trust	N/A
Terminated	Treatment of Faecal Incontinence With Sacral Nerve Stimulation - Improved Function With Stimulation Bilaterall NCT00913601	University of Aarhus	N/A
Completed	Study to Investigate Safety and Response to 1 or 2 g Rectal Suppositories Containing 5 or 10 mg NRL001. NCT00857467	Norgine	Phase 1
Unknown	Pilot Study of NASHA/Dx Gel for Fecal Incontinence NCT00971269	Uppsala University Hospital	Phase 1 / Phase 2
Completed	Feasibility Study of the Magnetic Anal Sphincter (FENIX System) NCT01625221	Torax Medical Incorporated	N/A
Completed	A Placebo-Controlled Study of Clonidine for Fecal Incontinence. NCT00884832	Mayo Clinic	Phase 2
Completed	Efficacy and Mechanisms of Pharmacologic Treatment of Fecal Incontinence NCT00727649	US Department of Veterans Affairs	Phase 2 / Phase 3
Completed	Adaptive Behaviors Among Women With Bowel Incontinence: The ABBI Trial NCT00729144	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	—
Completed	EPIC :Anal Incontinence After Delivery. Secondary Prevention With Caesarean Section. NCT00632567	Assistance Publique - Hôpitaux de Paris	N/A
Completed	Sierra High Definition Ano-Rectal Manometry NCT01300884	Augusta University	—
Terminated	Treatment of Patients With Fecal Incontinence NCT00292318	US Department of Veterans Affairs	N/A
Terminated	A Feasibility Study of a Fecal Incontinence Management System for Medical Use NCT00556972	Coloplast A/S	N/A
Completed	Study to Evaluate Solesta for Treatment of Fecal Incontinence NCT01110681	Galderma R&D	N/A
Completed	Evaluation of Outcomes of Restoring Pelvic Floor Support With TOPAS in Women With Moderate Fecal Incontinence NCT00565136	ASTORA Women's Health	Phase 1 / Phase 2
Unknown	Tibial Nerve Stimulation for Faecal Incontinence NCT00530933	London North West Healthcare NHS Trust	N/A
Withdrawn	Efficacy of Sacral Nerve Stimulation Before Definitive Implantation NCT00522691	University of Lausanne Hospitals	N/A
Unknown	The Immune Reactivity of Biofilms in Vaginal Mesh Erosion. NCT00564044	Chang Gung Memorial Hospital	N/A
Completed	Improving Women's Health by Using an Electronic Pelvic Floor Questionnaire NCT00880880	University of Wisconsin, Madison	N/A
Completed	Triple Target Treatment (3T) Which Combines Stimulation With Amplitude Modulated Middle Frequency (AM-MF), Ele NCT00525291	University of Giessen	Phase 3
Completed	Safety and Tolerability of a Single Intra-anal Dose of NRL001 in Healthy Volunteers NCT01406925	Norgine	Phase 1
Completed	Effect of Single Doses of 10 mg NRL001 Applied as a Suppository to the Anal Canal or Rectum NCT00893607	Norgine	Phase 1
Completed	The Role of Biofeedback in Improving Continence After Anterior Resection NCT00515853	University of Southampton	N/A
Completed	A Randomized, Blinded, Multicenter Study to Evaluate NASHA/Dx for the Treatment of Fecal Incontinence NCT00605826	Bausch Health Americas, Inc.	N/A
Completed	Evaluation of Potential Vitamin D Effects on Muscle: a Pilot Study NCT00593996	University of Wisconsin, Madison	N/A
Completed	A Randomized, Controlled, Clinical Trial of Biofeedback and Anal Injections as First Treatment of Fecal Incont NCT00303030	University Hospital of North Norway	Phase 1
Completed	A Colonic Tube to Improve Bowel Function in Spinal Cord Injury NCT00345397	VA Office of Research and Development	N/A
Terminated	Vaginal Estrogen for the Treatment of Faecal Incontinence in Women NCT00307775	London North West Healthcare NHS Trust	N/A
Completed	Development of an Instrument to Measure Quality of Life in Children With Chronic Constipation and Soiling NCT00677508	Medical College of Wisconsin	—
Withdrawn	Comparison of Rectal Trumpet and Standard Care NCT00307476	Christiana Care Health Services	N/A
Completed	Diagnosis of Functional Defecation Disorders in Childhood NCT00230360	University of Aarhus	—
Completed	Effect of Lumbo-sacral Magnetic Stimulation on Colonic Motility NCT00213317	University Hospital, Rouen	—
Terminated	A Prospective, Multi-center, Randomized, Blinded Study to Evaluate Durasphere FI for the Treatment of Fecal In NCT00762047	Carbon Medical Technologies	Phase 2
Completed	Dietary Fiber for Fecal Incontinence NCT01738607	University of Minnesota	N/A
Completed	Safety and Efficacy of Anorectal Application of Dx-gel for Treatment of Anal Incontinence NCT01380132	Uppsala University Hospital	Phase 1 / Phase 2
Terminated	Comparison of Esophageal and Anorectal Manometry Catheters NCT00204763	University of Utah	Phase 4
Completed	Treatment of Fecal Incontinence and Constipation in Patients With Spinal Cord Injury NCT00286520	University of Aarhus	Phase 4
Completed	Recurrence and Bowel Function After Laparoscopic Vaginorectopexy, a Modified Anterior Rectopexy NCT06330857	Sahlgrenska University Hospital	N/A
Completed	Combination Therapy With Biofeedback, Loperamide and Stool Bulking Agents NCT02165475	University Hospital, Linkoeping	N/A
Completed	Sacral Nerve Stimulation Therapy for the Treatment of Chronic Fecal Incontinence NCT00200057	MedtronicNeuro	N/A
Completed	Biofeedback for Fecal Incontinence NCT00124904	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	N/A
No Longer Available	Clinical Use of a Magnetic Anal Sphincter Augmentation Device, Trade Name FENIX NCT02722707	Mayo Clinic	—
Terminated	Safety Study of Autologous Cultured Adipose -Derived Stem Cells for the Fecal Incontinence NCT01011686	Anterogen Co., Ltd.	Phase 1